Related references
Note: Only part of the references are listed.BET-HDAC Dual Inhibitors for Combinational Treatment of Breast Cancer and Concurrent Candidiasis
Yahui Huang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2023)
Modulation of Virulence-Associated Traits in Aspergillus fumigatus by BET Inhibitor JQ1
Anastasia Orekhova et al.
MICROORGANISMS (2022)
The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin
Martin Hoenigl et al.
DRUGS (2021)
4-Acyl Pyrrole Capped HDAC Inhibitors: A New Scaffold for Hybrid Inhibitors of BET Proteins and Histone Deacetylases as Antileukemia Drug Leads
Linda Schaeker-Huebner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Potent Dual BET/HDAC Inhibitors for Efficient Treatment of Pancreatic Cancer
Shipeng He et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
Drug resistance and tolerance in fungi
Judith Berman et al.
NATURE REVIEWS MICROBIOLOGY (2020)
Discovery of Thieno[2,3-d]pyrimidine-Based Hydroxamic Acid Derivatives as Bromodomain-Containing Protein 4/Histone Deacetylase Dual Inhibitors Induce Autophagic Cell Death in Colorectal Carcinoma Cells
Zhaoping Pan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Discovery of Novel Fungal Lanosterol 14α-Demethylase (CYP51)/Histone Deacetylase Dual Inhibitors to Treat Azole-Resistant Candidiasis
Guiyan Han et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Histone acetylation/deacetylation inCandida albicansand their potential as antifungal targets
Shan Su et al.
FUTURE MICROBIOLOGY (2020)
Structural basis for species-selective targeting of Hsp90 in a pathogenic fungus
Luke Whitesell et al.
NATURE COMMUNICATIONS (2019)
Discovery of Simplified Sampangine Derivatives with Potent Antifungal Activities against Cryptococcal Meningitis
Zhuang Li et al.
ACS INFECTIOUS DISEASES (2019)
Discovery of simplified sampangine derivatives as novel fungal biofilm inhibitors
Na Liu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Epigenetic Control of Oxidative Stresses by Histone Acetyltransferases in Candida albicans
Jueun Kim et al.
JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY (2018)
Discovery of N-(4-(2,4-Difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl)ethanesulfonamide (ABBV-075/Mivebresib), a Potent and Orally Available Bromodomain and Extraterminal Domain (BET) Family Bromodomain Inhibitor
Keith F. McDaniel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
The Search for Potent, Small-Molecule HDACIs in Cancer Treatment: A Decade After Vorinostat
Chiara Zagni et al.
MEDICINAL RESEARCH REVIEWS (2017)
Portrait of Candida Species Biofilm Regulatory Network Genes
Daniela Araujo et al.
TRENDS IN MICROBIOLOGY (2017)
Structure-based design, synthesis and in vitro antiproliferative effects studies of novel dual BRD4/HDAC inhibitors
Mingfeng Shao et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Synthesis and evaluation of novel dual BRD4/HDAC inhibitors
Seika Amemiya et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Inhibition of BET bromodomains alleviates inflammation in human RPE cells
M. Hytti et al.
BIOCHEMICAL PHARMACOLOGY (2016)
Inhibiting fungal multidrug resistance by disrupting an activator-Mediator interaction
Joy L. Nishikawa et al.
NATURE (2016)
The Paralogous Histone Deacetylases Rpd3 and Rpd31 Play Opposing Roles in Regulating the White-Opaque Switch in the Fungal Pathogen Candida albicans
Jing Xie et al.
MBIO (2016)
Histone Deacetylases and Their Inhibition in Candida Species
Cecile Garnaud et al.
FRONTIERS IN MICROBIOLOGY (2016)
Candida albicans Biofilms and Human Disease
Clarissa J. Nobile et al.
ANNUAL REVIEW OF MICROBIOLOGY, VOL 69 (2015)
The Rpd3/Hda1 family of histone deacetylases regulates azole resistance in Candida albicans
Xiaofang Li et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Histone deacetylase-mediated morphological transition in Candida albicans
Jueun Kim et al.
JOURNAL OF MICROBIOLOGY (2015)
Targeting bromodomains: epigenetic readers of lysine acetylation
Panagis Filippakopoulos et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Frequent detection of 'azole' resistant Candida species among late presenting AIDS patients in northwest Ethiopia
Andargachew Mulu et al.
BMC INFECTIOUS DISEASES (2013)
Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme
M. C. Arendrup et al.
CLINICAL MICROBIOLOGY AND INFECTION (2013)
Invasive candidiasis: update on current pharmacotherapy options and future perspectives
Athanasios Tragiannidis et al.
EXPERT OPINION ON PHARMACOTHERAPY (2013)
BET acetyl-lysine binding proteins control pathological cardiac hypertrophy
Jessica I. Spiltoir et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2013)
RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain
Sarah Picaud et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
BET domain co-regulators in obesity, inflammation and cancer
Anna C. Belkina et al.
NATURE REVIEWS CANCER (2012)
Selective inhibition of BET bromodomains
Panagis Filippakopoulos et al.
NATURE (2010)
Identification of Nile red as a fluorescent substrate of the Candida albicans ATP-binding cassette transporters Cdr1p and Cdr2p and the major facilitator superfamily transporter Mdr1p
Irena Ivnitski-Steele et al.
ANALYTICAL BIOCHEMISTRY (2009)
International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
Jean-Louis Vincent et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Histone deacetylase inhibitors may reduce pathogenicity and virulence in Candida albicans
Giovanna Simonetti et al.
FEMS YEAST RESEARCH (2007)
The transcription factor Mrr1p controls expression of the MDR1 efflux pump and mediates multidrug resistance in Candida albicans
Joachim Morschhaeuser et al.
PLOS PATHOGENS (2007)
Discovery of uracil-based histone deacetylase inhibitors able to reduce acquired antifungal resistance and trailing growth in Candida albicans
Antonello Mai et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Histone deacetylase inhibitors in cancer treatment:: A review of the clinical toxicity and the modulation of gene expression in cancer cells
O. Bruserud et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2007)
Histone deacetylases in fungi: novel members, new facts
P Trojer et al.
NUCLEIC ACIDS RESEARCH (2003)
Bromodomain: an acetyl-lysine binding domain
L Zeng et al.
FEBS LETTERS (2002)